Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

ARNA 4.23 0.00 (0.00%)
price chart
Notable Movers:Arena Pharmaceuticals, Inc. (ARNA), TriQuint Semiconductor ...
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) reported the gain of 0.71% and closed at $4.23with the total traded volume of 4.39 million shares.
Traders Alert - Arena Pharmaceuticals, Inc (NASDAQ:ARNA), TriQuint ...
Las Vegas, NV - August 20, 2014 - (Tech Sonian) �Arena Pharmaceuticals, Inc (NASDAQ:ARNA) recently provided a corporate update and reported financial results for the second quarter ended June 30, 2014.
What Do Today's Gains Represent For These Companies? Arena ...  NIS
Special News Alert: OncothyreonInc (USA) (NASDAQ:ONTY), Ariad ...  Market News Call
Related articles »  
Concerns on Biotech Stocks- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) [Trend Analysis] recently delivered Belviq sales of $3.5M (including $0.4 million from the 15-day free trial voucher redemption).
Related articles »  
Trending Tickers : Arena Pharmaceuticals (NASDAQ:ARNA), The Coca-Cola ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) on Aug. 1 provided a corporate update and reported financial results for the second quarter ended June 30, 2014.
Arena Pharmaceuticals Posts Increased Revenue In Second Quarter
Arena Pharmaceuticals, Inc. (ARNA) reported financial results for the second quarter of its fiscal year 2014 (2QFY14) before the market opened today.
Arena Pharmaceuticals Provides Corporate Update and Reports Second ...  MarketWatch
Related articles »  
Trending Stocks: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Net Element ...
On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14.
Small Cap Obesity Stock Orexigen Therapeutics (OREX) Awaits Its Fate (ARNA ...
Small cap biotech Orexigen Therapeutics, Inc (OREX) is developing an obesity drug with a FDA Prescription Drug User Fee Act (PDUFA) action date set for September 11 plus a look at the so-so performance of obesity stocks Arena Pharmaceuticals, Inc ...
Watch List: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Alpha Natural ...
Lakeway, NY - (MARKET NEWS CALL) - 8/19/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Dips As Loss Goes Beyond ...
Dallas, Texas 08/05/2014 (FINANCIALSTRENDS) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported a loss of 3.7% in its second quarterly results.
Arena Pharmaceuticals Falls on Wider-than-Expected Q2 Loss - Analyst Blog  NASDAQ
Related articles »  
Arena Pharmaceuticals Receives Consensus Rating of �Hold� from Brokerages ...
Arena Pharmaceuticals (NASDAQ:ARNA) last announced its earnings results on Friday, August 1st. The company reported $0.03 earnings per share for the quarter, beating the analysts' consensus estimate of ($0.11) by $0.14.
Volatile Stocks to Watch - dELiA*s, Inc.(NASDAQ:DLIA),Arena Pharmaceuticals ...  Techsonian (press release)
Related articles »